Abstract
We retrospectively collected information about 29 cancer patients who underwent measurement of their plasma concentration (PC) of voriconazole (VRC) (2002-2006). Nine patients (31%) had VRC PC <1 μg/ml. VRC PC <1 μg/ml occurred in 7 of 10 patients who were on VRC >2 months versus only 2 of 19 patients who were on VRC <2 months (P = 0.001). VRC PCs were infrequently ordered, did not follow clear indications, and the use of the results was variable.
Original language | English (US) |
---|---|
Pages (from-to) | e129-e130 |
Journal | Journal of Infection |
Volume | 55 |
Issue number | 5 |
DOIs | |
State | Published - Nov 2007 |
Keywords
- Cancer
- Fungal infections
- Voriconazole
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases